Spectroscopic, Thermodynamic and Molecular Docking Studies on Molecular Mechanisms of Drug Binding to Proteins
This reprint contains several articles where the molecular mechanisms and structural changes in target proteins on interaction with various viruses and bacteria were studied. In addition, drug-protein interactions, drug-drug interaction mechanisms, anti-Glycating, antioxidant, binding affinity, netw...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_96629 | ||
| 005 | 20230202 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230202s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-6225-4 | ||
| 020 | |a 9783036562261 | ||
| 020 | |a 9783036562254 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6225-4 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Wani, Tanveer A. |4 edt | |
| 700 | 1 | |a Zargar, Seema |4 edt | |
| 700 | 1 | |a Hussain, Afzal |4 edt | |
| 700 | 1 | |a Wani, Tanveer A. |4 oth | |
| 700 | 1 | |a Zargar, Seema |4 oth | |
| 700 | 1 | |a Hussain, Afzal |4 oth | |
| 245 | 1 | 0 | |a Spectroscopic, Thermodynamic and Molecular Docking Studies on Molecular Mechanisms of Drug Binding to Proteins |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (276 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This reprint contains several articles where the molecular mechanisms and structural changes in target proteins on interaction with various viruses and bacteria were studied. In addition, drug-protein interactions, drug-drug interaction mechanisms, anti-Glycating, antioxidant, binding affinity, network pharmacology-driven investigations, and targeted anticancer treatments were also investigated. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a RSV | ||
| 653 | |a ectodomain G protein | ||
| 653 | |a heparan sulfate | ||
| 653 | |a protein-ligand interaction | ||
| 653 | |a fluorescence quenching | ||
| 653 | |a molecular docking | ||
| 653 | |a molecular dynamic simulation | ||
| 653 | |a quercetin | ||
| 653 | |a CCL4 | ||
| 653 | |a neurotoxicity | ||
| 653 | |a VirtualToxLab | ||
| 653 | |a oxidative stress markers | ||
| 653 | |a Huperzine A | ||
| 653 | |a molecular dynamics simulation | ||
| 653 | |a fluorescence spectroscopy | ||
| 653 | |a human serum albumin | ||
| 653 | |a neurodegenerative disorders | ||
| 653 | |a drug-protein interactions | ||
| 653 | |a erlotinib | ||
| 653 | |a bovine serum albumin | ||
| 653 | |a binding interaction | ||
| 653 | |a competition | ||
| 653 | |a hepatitis E virus | ||
| 653 | |a methyltransferase | ||
| 653 | |a protein stability | ||
| 653 | |a enzyme assay | ||
| 653 | |a garlic | ||
| 653 | |a antioxidant | ||
| 653 | |a anti-glycation | ||
| 653 | |a glycation | ||
| 653 | |a AGEs | ||
| 653 | |a HSA | ||
| 653 | |a quetiapine | ||
| 653 | |a hydrophobic interaction | ||
| 653 | |a thermodynamic parameters | ||
| 653 | |a seproxetine | ||
| 653 | |a antidepressant | ||
| 653 | |a charge transfer | ||
| 653 | |a π-acceptors | ||
| 653 | |a DFT | ||
| 653 | |a haloperidol | ||
| 653 | |a antipsychotics | ||
| 653 | |a keratoconus | ||
| 653 | |a MMP-2 | ||
| 653 | |a MMP-9 | ||
| 653 | |a molecular dynamics | ||
| 653 | |a MM-GBSA calculations | ||
| 653 | |a pharmacophore mapping | ||
| 653 | |a α-amylase | ||
| 653 | |a advanced glycation end-products | ||
| 653 | |a caffeic acid | ||
| 653 | |a coumaric acid | ||
| 653 | |a coronary artery disease | ||
| 653 | |a phytotherapy | ||
| 653 | |a network pharmacology | ||
| 653 | |a angiogenesis | ||
| 653 | |a zebrafish | ||
| 653 | |a dynamics molecular docking | ||
| 653 | |a NEK7 | ||
| 653 | |a virtual screening | ||
| 653 | |a DFTs | ||
| 653 | |a deep learning | ||
| 653 | |a drug design | ||
| 653 | |a drug repurposing | ||
| 653 | |a structural-based | ||
| 653 | |a cancer | ||
| 653 | |a A. aspera | ||
| 653 | |a β-amyrin | ||
| 653 | |a C. gigantea | ||
| 653 | |a C. procera | ||
| 653 | |a GC-MS | ||
| 653 | |a Minimum inhibitory concentration (MIC) | ||
| 653 | |a Molecular docking | ||
| 653 | |a MD simulations | ||
| 653 | |a Tuberculosis (TB) | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6574 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/96629 |7 0 |z DOAB: description of the publication |